Abstract
Purpose Biallelic pathogenic variants in the mismatch repair (MMR) genes cause a recessive childhood cancer predisposition syndrome known as constitutional mismatch repair deficiency (CMMRD). Family members with a heterozygous MMR-variant have Lynch syndrome. We aimed at estimating cancer risk in these heterozygous carriers as a novel approach to avoid complicated statistical methods to correct for ascertainment bias.
Methods Cumulative colorectal cancer incidence was estimated in a cohort of PMS2- and MSH6-associated families, ascertained by the CMMRD phenotype of the index, by using mutation probabilities based on kinship coefficients as analytical weights in a proportional hazard regression on the cause-specific hazards. Confidence intervals (CI) were obtained by bootstrapping at family level.
Results The estimated cumulative colorectal cancer risk at age 70 years for heterozygous PMS2 variant carriers was 8.7% (95%CI 4.3-12.7%) for both sexes combined, and 9.9% (95%CI 4.9-15.3%) for men and 5.9% (95%CI 1.6-11.1%) for women separately. For heterozygous MSH6 variant carriers these estimates are 11.8% (95%CI 4.5-22.7%) for both sexes combined, 10.0% (95%CI 1.83-24.5%) for men and 11.7% (95%CI 2.10-26.5%) for women.
Conclusion Our findings are consistent with previous reports that used more complex statistical methods to correct for ascertainment bias. These results underline the need for MMR gene-specific surveillance protocols for Lynch syndrome.
Methods Cumulative colorectal cancer incidence was estimated in a cohort of PMS2- and MSH6-associated families, ascertained by the CMMRD phenotype of the index, by using mutation probabilities based on kinship coefficients as analytical weights in a proportional hazard regression on the cause-specific hazards. Confidence intervals (CI) were obtained by bootstrapping at family level.
Results The estimated cumulative colorectal cancer risk at age 70 years for heterozygous PMS2 variant carriers was 8.7% (95%CI 4.3-12.7%) for both sexes combined, and 9.9% (95%CI 4.9-15.3%) for men and 5.9% (95%CI 1.6-11.1%) for women separately. For heterozygous MSH6 variant carriers these estimates are 11.8% (95%CI 4.5-22.7%) for both sexes combined, 10.0% (95%CI 1.83-24.5%) for men and 11.7% (95%CI 2.10-26.5%) for women.
Conclusion Our findings are consistent with previous reports that used more complex statistical methods to correct for ascertainment bias. These results underline the need for MMR gene-specific surveillance protocols for Lynch syndrome.
Original language | English |
---|---|
Journal | Genetics in Medicine |
Early online date | 17 Jun 2019 |
DOIs | |
Publication status | Published - 2019 |
Keywords
- HNPCC
- colon cancer risk
- PMS2
- MSH6
- bMMRD